Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1167557 Greenwich, CT
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$27,101,712
+$3,794,033 QoQ
Shares Held
332,251
-2.9% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#57
of 383 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. PTCT ranks #23 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in PTCT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,101,712 332,251
2026-03-31 $23,307,679 342,106
2025-12-31 $25,972,773 341,927
2025-09-30 $20,329,179 331,256
2025-06-30 $26,232,744 537,116
2025-03-31 $21,047,649 413,023
2024-12-31 $7,102,733 157,349
2024-09-30 $7,033,380 189,579
2024-06-30 $2,107,327 68,912
2024-03-31 $491,416 16,893
2023-12-31 $794,361 28,823
2023-09-30 $2,474,086 110,401
2023-06-30 $2,951,421 72,570
2023-03-31 $3,243,493 66,959
2022-12-31 $2,381,578 62,394
2022-09-30 $648,533 12,919
2022-06-30 $481,320 12,015
2022-03-31 $1,342,227 35,975
2021-12-31 $208,191 5,227
2021-03-31 $217,005 4,583
2020-12-31 $656,377 10,755
2020-09-30 $1,298,902 27,784
2020-06-30 $3,941,584 77,682
2020-03-31 $3,865,813 86,658